In the central nervous system (CNS), innate immune surveillance is mainly coordinated by microglia. These CNS resident myeloid cells are assumed to help orchestrate the immune response against infections of the brain. However, their specific role in this process and their interactions with CNS infiltrating immune cells, such as blood-borne monocytes and T cells are only incompletely understood. The recent development of PLX5622, a specific inhibitor of colony-stimulating factor 1 receptor that depletes microglia, allows studying the role of microglia in conditions of brain injury such as viral encephalitis, the most common form of brain infection. Here we used this inhibitor in a model of viral infection-induced epilepsy, in which C57BL/6 mice are infected by a picornavirus (Theiler's murine encephalomyelitis virus) and display seizures and hippocampal damage. Our results show that microglia are required early after infection to limit virus distribution and persistence, most likely by modulating T cell activation. Microglia depletion accelerated the occurrence of seizures, exacerbated hippocampal damage, and led to neurodegeneration in the spinal cord, which is normally not observed in this mouse strain. This study enhances our understanding of the role of microglia in viral encephalitis and adds to the concept of microglia-T cell crosstalk.
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Introduction
Viral encephalitis is the most common form of brain infection and can cause severe and life-threatening consequences, including epilepsy (Vezzani et al., 2016) . Monocyte infiltration and activation of microglia, the resident macrophage population of the brain, are hallmarks of CNS inflammation, including viral infection (Prinz and Priller, 2017) . However, the role of these cells in viral clearance and immunopathology is not well defined. At least in part this is due to the problems of differentiating invading monocytes from activated microglia in the brain and the lack of selective tools to manipulate these two types of myeloid cells. In several viral brain infections, activated microglia appears to be involved in inhibition of viral replication and in neurotoxicity, indicating the dual nature of microglia: they contribute to the defense of the CNS but may also bear responsibility for CNS damage (Rock et al., 2004) . Microglia expresses various Pattern Recognition Receptors (PRRs) to identify viral signatures called Pathogen Associated Molecular Patterns (PAMPs). Upon stimulation by PAMPs microglia respond by releasing several pro-and anti-inflammatory cytokines such as monocyte chemoattractant protein 1 (MCP1/CCL2), interleukin (IL)-1β, type I interferon (IFN), IFNγ, and tumor necrosis factor (TNF)α (O'Shea et al., 2013) .
Recently, a new compound, PLX5622, which acts as specific dietary inhibitor of colony stimulating factor-1 receptor (CSF1R), a tyrosine kinase transmembrane receptor essential for the survival and activation of monocytes and macrophages in the periphery and microglia in the CNS (Erblich et al., 2011; Hamilton and Achuthan, 2013; Elmore et al., 2014) , was shown to efficiently eliminate microglia in mice (Dagher et al., 2015) . Similar to the less specific CSF1R inhibitor PLX3397 (Elmore et al., 2015) , PLX5622 has been used to study the role of microglia in several conditions of brain injury (Acharya et al., 2016; Feng et al., 2016; Beckers et al., 2017; Hilla et al., 2017 
